scanX
Home
Titan Biotech

Titan Biotech

893.60
-16.85
(-1.85%)
Market Cap (₹ Cr.)
₹738
52 Week High
1,017.85
Book Value
₹161
52 Week Low
355.00
PE Ratio
29.43
PB Ratio
5.53
PE for Sector
39.83
PB for Sector
4.62
ROE
19.13 %
ROCE
23.79 %
Dividend Yield
0.22 %
EPS
₹30.36
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
13.62 %
Net Income Growth
12.55 %
Cash Flow Change
-0.14 %
ROE
-7.31 %
ROCE
-11.13 %
EBITDA Margin (Avg.)
0.79 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
12
9
12
12
13
12
13
13
15
12
15
15
14
15
15
14
16
18
16
18
18
35
27
31
30
33
30
29
31
35
43
31
37
35
44
46
40
44
Expenses
11
8
11
11
11
11
12
11
13
11
13
13
13
13
13
12
14
15
14
15
15
18
17
22
24
22
23
22
24
27
31
26
30
27
35
35
33
35
EBITDA
1
1
1
1
1
1
1
1
2
1
2
2
2
2
2
2
2
3
3
3
3
17
10
9
6
11
7
7
7
8
11
4
7
8
9
11
8
9
Operating Profit %
10 %
10 %
9 %
8 %
8 %
9 %
8 %
9 %
12 %
12 %
14 %
14 %
8 %
13 %
13 %
14 %
11 %
15 %
15 %
16 %
17 %
48 %
36 %
29 %
20 %
34 %
23 %
22 %
23 %
23 %
25 %
14 %
19 %
23 %
20 %
23 %
18 %
19 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
-0
1
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Interest
0
0
0
0
0
0
0
0
0
0
1
1
1
0
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
16
9
9
5
10
6
6
6
8
11
4
6
7
8
10
6
8
Tax
0
0
0
0
0
0
0
0
0
0
1
0
-0
0
0
0
0
0
0
1
0
4
2
2
1
3
1
1
2
2
3
1
2
2
2
3
1
2
Net Profit
0
0
0
0
1
0
1
0
1
0
0
1
1
1
1
1
1
1
1
2
2
12
7
6
3
7
5
4
5
6
8
3
5
5
6
7
5
6
EPS in ₹
0.54
0.49
0.54
0.55
0.64
0.58
0.74
0.43
1.25
0.64
0.50
1.01
0.95
0.90
1.14
0.98
0.77
1.49
1.62
2.06
2.34
14.76
8.22
7.76
4.09
9.00
6.07
5.36
5.81
6.99
9.56
3.27
5.62
6.55
7.30
8.93
5.86
6.90
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
34
39
50
55
60
65
86
108
131
152
Fixed Assets
11
10
11
11
26
25
27
35
36
52
Current Assets
21
22
29
29
32
38
50
64
68
72
Capital Work in Progress
1
5
9
13
0
0
0
4
13
3
Investments
0
0
1
1
1
1
1
4
12
23
Other Assets
22
24
29
29
33
39
58
65
70
74
Total Liabilities
13
17
27
31
28
27
20
22
25
23
Current Liabilities
10
13
12
11
14
16
15
17
20
19
Non Current Liabilities
3
5
15
20
14
11
6
5
4
4
Total Equity
20
21
23
24
32
38
66
86
106
128
Reserve & Surplus
13
14
15
17
23
30
58
78
98
120
Share Capital
8
8
8
8
8
8
8
8
8
8
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-2
2
2
-3
1
0
4
2
-2
-2
Investing Activities
-3
-5
-7
-5
-4
-1
-4
-16
-21
-20
Operating Activities
-2
5
-0
2
6
7
18
22
21
21
Financing Activities
3
2
8
0
-2
-6
-10
-4
-2
-3
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
55.88 %
55.88 %
55.88 %
55.88 %
55.88 %
55.88 %
55.88 %
55.88 %
55.88 %
55.88 %
55.88 %
55.88 %
55.88 %
55.88 %
55.88 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.23 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
44.12 %
44.12 %
44.12 %
44.12 %
44.12 %
44.12 %
44.12 %
44.12 %
44.12 %
44.12 %
44.12 %
44.12 %
43.90 %
44.12 %
44.12 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,790.95 4,29,840.88 38.35 49,887.17 12.06 9,648 27.35 37.35
Cipla
1,576.15 1,27,063.03 27.53 26,520.66 14.17 4,155 12.95 51.87
Mankind Pharma
2,727.00 1,09,233.62 51.65 10,615.63 19.57 1,942 28.89 59.29
Dr Reddys Laboratories
1,287.35 1,07,397.83 20.12 28,905.40 12.36 5,578 -9.47 43.55
Zydus Life Science
973.25 97,866.32 23.48 19,831.50 13.82 3,831 30.78 33.46
Lupin
2,111.50 96,282.22 42.53 20,141.50 19.94 1,936 77.69 42.24
Aurobindo Pharma
1,350.60 79,131.01 22.06 29,559.25 17.55 3,169 61.17 25.76
Alkem Laboratories
5,723.80 68,407.92 31.82 12,978.42 9.84 1,811 91.18 39.67
Glenmark Pharmaceuticals
1,657.35 46,778.33 - 12,653.09 6.58 -1,831 96.52 43.98
IPCA Laboratories
1,558.40 39,515.70 67.31 7,829.81 22.92 529 21.35 48.25

Corporate Action

Technical Indicators

RSI(14)
Neutral
58.43
ATR(14)
Less Volatile
61.23
STOCH(9,6)
Neutral
59.96
STOCH RSI(14)
Neutral
20.86
MACD(12,26)
Bearish
-6.75
ADX(14)
Strong Trend
32.61
UO(9)
Bearish
51.44
ROC(12)
Downtrend And Accelerating
-8.51
WillR(14)
Neutral
-57.25
Bearish
5
Neutral
3
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Price & Volume Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.